159 related articles for article (PubMed ID: 16025164)
1. Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.
Piosik J; Gwizdek-Wiśniewska A; Ulanowska K; Ochociński J; Czyz A; Wegrzyn G
Acta Biochim Pol; 2005; 52(4):923-6. PubMed ID: 16025164
[TBL] [Abstract][Full Text] [Related]
2. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
Traganos F; Kapuscinski J; Darzynkiewicz Z
Cancer Res; 1991 Jul; 51(14):3682-9. PubMed ID: 2065324
[TBL] [Abstract][Full Text] [Related]
3. Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines.
Woziwodzka A; Gwizdek-Wiśniewska A; Piosik J
Bioorg Chem; 2011 Feb; 39(1):10-7. PubMed ID: 21146849
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline.
Piosik J; Ulanowska K; Gwizdek-Wiśniewska A; Czyz A; Kapuściński J; Wegrzyn G
Mutat Res; 2003 Sep; 530(1-2):47-57. PubMed ID: 14563530
[TBL] [Abstract][Full Text] [Related]
5. Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.
Ulanowska K; Piosik J; Gwizdek-Wiśniewska A; Wegrzyn G
Bioorg Med Chem; 2007 Aug; 15(15):5150-7. PubMed ID: 17533133
[TBL] [Abstract][Full Text] [Related]
6. Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines--analysis with mathematical models.
Gołuński G; Woziwodzka A; Iermak I; Rychłowski M; Piosik J
Bioorg Med Chem; 2013 Jun; 21(11):3280-9. PubMed ID: 23601817
[TBL] [Abstract][Full Text] [Related]
7. Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Ulanowska K; Wegrzyn G
J Appl Genet; 2006; 47(1):85-7. PubMed ID: 16424614
[TBL] [Abstract][Full Text] [Related]
8. The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone.
Piosik J; Zdunek M; Kapuscinski J
Biochem Pharmacol; 2002 Feb; 63(4):635-46. PubMed ID: 11992631
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
Kule C; Ondrejickova O; Verner K
Mol Pharmacol; 1994 Dec; 46(6):1234-40. PubMed ID: 7808447
[TBL] [Abstract][Full Text] [Related]
10. Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.
Janitschke D; Lauer AA; Bachmann CM; Seyfried M; Grimm HS; Hartmann T; Grimm MOW
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260941
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of alkaline phosphatase activity of boar semen by pentoxifylline, caffeine, and theophylline.
Glogowski J; Danforth DR; Ciereszko A
J Androl; 2002; 23(6):783-92. PubMed ID: 12399523
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
[TBL] [Abstract][Full Text] [Related]
13. Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of Trp-P-1 and Trp-P-2 mutagenic activity.
Woziwodzka A; Gołuński G; Wyrzykowski D; Kaźmierkiewicz R; Piosik J
Chem Res Toxicol; 2013 Nov; 26(11):1660-73. PubMed ID: 24102551
[TBL] [Abstract][Full Text] [Related]
14. The modulation of the DNA-damaging effect of polycyclic aromatic agents by xanthines. Part I. Reduction of cytostatic effects of quinacrine mustard by caffeine.
Kapuscinski J; Ardelt B; Piosik J; Zdunek M; Darzynkiewicz Z
Biochem Pharmacol; 2002 Feb; 63(4):625-34. PubMed ID: 11992630
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline as a modulator of anticancer drug doxorubicin. Part I: Reduction of doxorubicin DNA binding.
Gołuński G; Borowik A; Wyrzykowski D; Woziwodzka A; Piosik J
Chem Biol Interact; 2015 Dec; 242():291-8. PubMed ID: 26499448
[TBL] [Abstract][Full Text] [Related]
16. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
Sadzuka Y; Iwazaki A; Miyagishima A; Nozawa Y; Hirota S
Jpn J Cancer Res; 1995 Jun; 86(6):594-9. PubMed ID: 7622424
[TBL] [Abstract][Full Text] [Related]
18. Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
Drewinko B; Yang LY; Barlogie B; Trujillo JM
Cancer Res; 1983 Jun; 43(6):2648-53. PubMed ID: 6850582
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline as a modulator of anticancer drug doxorubicin. Part II: Reduction of doxorubicin DNA binding and alleviation of its biological effects.
Gołuński G; Borowik A; Derewońko N; Kawiak A; Rychłowski M; Woziwodzka A; Piosik J
Biochimie; 2016 Apr; 123():95-102. PubMed ID: 26855172
[TBL] [Abstract][Full Text] [Related]
20. Methylxanthines and inflammatory cells.
Haskó G; Cronstein B
Handb Exp Pharmacol; 2011; (200):457-68. PubMed ID: 20859808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
